|
|
||||||||||||||
|
|
|||||||||||||||
1 Institute of Laboratory Medicine, Department of Clinical Chemistry, University Hospital, S-221 85 Lund, Sweden
2 Department of Pediatrics, University Hospital, S-205 02 Malmö, Sweden
3 MRC Lipoprotein Team, Hammersmith Hospital, Ducane Road, LondonW12 OHS, UK
Correspondence: Dr Ekström email: ulf.ekstrom{at}klinkem.lu.se
AimsTo investigate the disease causing event in patients with familial hypercholesterolaemia, carrying two mutations each, E256K in exon 6 and I402T in exon 9, of the gene encoding the low density lipoprotein (LDL) receptor. It was not known whether the mutations were positioned in cis or trans, or if they were each pathogenic separately or only when present together.
MethodsPolymerase chain reaction, denaturing gradient gel electrophoresis and sequencing were used to characterise the LDL receptor locus of the patients and family members. The different LDL receptor mutants, constructed in vitro by oligonucleotide directed mutagenesis, were expressed in LDL receptor deficient Chinese hamster ovary (CHOldlA7) cells, to determine the effects of the mutations on LDL receptor function.
ResultsThe two mutations were located on the same allele of the LDL receptor gene. All mutant constructs resulted in the production of a detectable protein in CHO cells. The cells expressing only the I402T mutation, or the combination of I402T and E256K mutations, were seriously affected in mediating uptake and degradation of LDL. Contrary to initial predictions, the cells expressing only the E256K mutation showed essentially the same binding, uptake, and degradation of 125I labelled LDL as cells transfected with normal LDL receptor cDNA. These results suggest that the pathogenic mutation in the patients heterozygous for the E256K/I402T allele is the I402T mutation, and that E256K alone is a rare sequence variation, which does not affect LDL receptor protein function. E256K was not detected either in DNA from a healthy population or in DNA from other hypercholesterolaemic patients studied.
ConclusionsDespite the information available on the structurefunction relations between the LDL receptor and LDL receptor like proteins, predictions about the disease causing potential of a mutation are not reliable. These results suggest that the I402T mutation is pathogenic and that the substitution of E256K alone is a rare sequence variation, without a detectable phenotype modulating effect.
Key Words: low density lipoprotein receptor expression mutation familial hypercholesterolaemia
This article has been cited by other articles:
![]() |
E. R. Eden, X.-M. Sun, D. D. Patel, and A. K. Soutar Adaptor protein Disabled-2 modulates low density lipoprotein receptor synthesis in fibroblasts from patients with autosomal recessive hypercholesterolaemia Hum. Mol. Genet., November 15, 2007; 16(22): 2751 - 2759. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Blesa, A. B. Garcia-Garcia, S. Martinez-Hervas, M. L. Mansego, V. Gonzalez-Albert, J. F. Ascaso, R. Carmena, J. T. Real, and F. J. Chaves Analysis of Sequence Variations in the LDL Receptor Gene in Spain: General Gene Screening or Search for Specific Alterations? Clin. Chem., June 1, 2006; 52(6): 1021 - 1025. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-H. Chang, J.-P. Pan, D.-Y. Tai, A.-C. Huang, P.-H. Li, H.-L. Ho, H.-L. Hsieh, S.-C. Chou, W.-L. Lin, E. Lo, et al. Identification and characterization of LDL receptor gene mutations in hyperlipidemic Chinese J. Lipid Res., October 1, 2003; 44(10): 1850 - 1858. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |
| Molecular Pathology | Journal of Clinical Pathology |